Cambridge Cancer Genomics

CCG.ai empowers clinicians to make personalised treatment strategies…

Cambridge Cancer Genomics is a business in healthcare based in Cambridge, England, United Kingdom; England, United Kingdom, founded in 2017.

Profile

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer.
‍
We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance.

We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated.

To apply, please send your CV to info@ccg.ai

Cambridge Cancer Genomics is positioned in healthcare, a segment that rewards a clear, focused offering.

The business is associated with Cambridge, England, United Kingdom; England, United Kingdom.

Directory data places it at the Summer 2017 stage.

The company reports a headcount in the 25 range.

Website: ccg.ai